Last reviewed · How we verify

NCT03056911

Clinical Effects of Ozone Therapy in Cervical Disc Hernia

Status unknown Last updated 17 February 2017
What this trial tests

trial testing Ozone in Pain, Neck in 43 participants. Status unknown.

Timeline
1 March 2017
Primary endpoint
1 January 2018
1 January 2019

Quick facts

Lead sponsorSakarya University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment43
Start date1 March 2017
Primary completion1 January 2018
Estimated completion1 January 2019
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Sakarya University

Who can join

Adults 18 to 70, any sex, with Pain, Neck. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to evaluate the clinical effects of Ozone-oxygen therapy as therapeutic substance for nucleolysis application in the patients with cervical disc hernia who had chronic pain and weakness on the neck, shoulders and arms

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Ozone in Chemotherapy-Induced Peripheral Neuropathy-Current State of Art, Possibilities, and Perspectives.
    Szklener K, Rudzińska A, Juchaniuk P, Kabała Z, et al · · 2023 · cited 8× · PMID 36982352 · DOI 10.3390/ijms24065279

Verify or expand the search:

Other trials of Ozone

Trials testing the same drug.

Other recruiting trials for Pain, Neck

Currently open trials in the same condition.

Other Sakarya University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03056911.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing